Raising Health
The Science and Supply of GLP-1s with Carolyn Jasik
May 28, 2024
Carolyn Jasik, Chief Medical Officer of Omada Health, discusses the science of GLP-1 medications, including satiety effects, perspectives of obesity-focused physicians, and lifestyle implications for patients. They explore the transformative potential, comprehensive care strategies, and impact on behavior change. Practical tips for healthy eating on the go are also shared.
29:42
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- GLP-1 medications offer promising weight loss results, potentially transforming societal norms around food consumption.
- Companion programs for GLP-1 medications can enhance patient support and manage side effects, driving future variations for chronic conditions.
Deep dives
Overview of GLP1 Medications
GLP1 medications have evolved over time, transitioning from daily to monthly dosing with improved side effect profiles. The medications are now categorized as anti-obesity drugs and show significant promise for weight loss, unlike previous disappointing outcomes in the field of obesity treatment.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
